NCT00222131View on ClinicalTrials.gov

Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Indigestion
Interventions
DRUG

Esomeprazole

Esomeprazole 40 mg QD

OTHER

Placebo

Placebo

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of Kansas Medical Center

OTHER